Search hospitals > Illinois > Chicago
Rush University Medical Center
Claim this profileChicago, Illinois 60612
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Parkinson's Disease
Conducts research for HIV Infection
Conducts research for Ovarian Cancer
1654 reported clinical trials
119 medical researchers
Summary
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Parkinson's Disease, HIV Infection, Ovarian Cancer and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,574 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and James Moy, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
Global LeaderHER2 positive
HER2 negative
ER positive
Top PIs
Alan TanRush University Medical Center5 years of reported clinical research
Studies Kidney Cancer
Studies Renal Cell Carcinoma
15 reported clinical trials
26 drugs studied
Dian Wang, MD, PhDRush University Medical Center8 years of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
14 reported clinical trials
39 drugs studied
Timothy M Kuzel, MDRush University Medical Center8 years of reported clinical research
Studies Melanoma
Studies Skin Cancer
10 reported clinical trials
35 drugs studied
James Moy, MDRush University Medical Center5 years of reported clinical research
Studies Coronavirus
Studies COVID-19
10 reported clinical trials
17 drugs studied
Clinical Trials running at Rush University Medical Center
Skin Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Cancer
Testicular cancer
Small Cell Lung Cancer
Kidney Cancer
Stroke
Uterine Cancer
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rush University Medical Center?
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Parkinson's Disease, HIV Infection, Ovarian Cancer and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,574 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and James Moy, MD.
Where is Rush University Medical Center located?
Rush University Medical Center is conveniently situated at 1620 W. Harrison St., Chicago, IL 60612, easily accessible from the Eisenhower Expressway (I-290) and just five minutes west of Chicago's Loop. Public transportation options include two nearby Chicago Transit Authority (CTA) train stations: Illinois Medical District (Blue Line) and Polk (Pink Line). Additionally, the area is served by several CTA bus routes: #7 Harrison, #9 Ashland, #126 Jackson, and #157 Streeterville/Taylor.
Who should I call to ask about financial aid or insurance network?
**Rush University Medical Center Financial Assistance and Insurance Information:**
- **Financial Assistance:** Contact at (312) 942-5693 or (866) 761-7812, or email billing_info@rush.edu. Office hours are Monday through Friday, 8 a.m. to 4:30 p.m.
- **Insurance Inquiries:** Contact the Insurance Department at (630) 978-2532 or visit [www.vnahealth.com](http://www.vnahealth.com). Address: VNA Health Center, 400 N. Highland Ave., Aurora, IL 60506.
What insurance does Rush University Medical Center accept?
Rush University Medical Center accepts a wide range of insurance plans, including HMO, POS, and PPO. RUSH Copley Medical Group specifically accepts commercial and governmental plans such as Aetna, Blue Cross/Blue Shield, Cigna, Humana, Medicare Part B, Medicare Advantage, Tricare, and United Healthcare. Short-term health insurance plans with PPO networks like Aetna or Cigna also typically provide coverage at Rush.
What awards or recognition has Rush University Medical Center received?
Rush University Medical Center, located in Chicago, Illinois, is renowned for its exceptional research and care. It has been designated as a Center of Excellence for Parkinson's Disease Program by the Parkinson's Foundation and a National Pancreas Foundation Center of Excellence for Pancreatic Cancer. The hospital also boasts accreditations from prestigious organizations including the American College of Surgeons' Commission on Cancer, the Foundation for the Accreditation of Cellular Therapy, and the American College of Radiology, highlighting its dedication to high-quality care and patient safety.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.